http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100136636-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff6e5d06aac7d7d14c6165bae5095c52 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-428 |
| filingDate | 2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c67af24eab8bd5949883a3a1e120ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abdc47dd5ede16fab5b13bc0613f97ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0950d4cba29e81b936802dc64c7ababa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c559a30bfd3e133b6c4d91f66cf3da4f |
| publicationDate | 2010-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100136636-A |
| titleOfInvention | Pharmaceutical composition for the prevention or treatment of inflammatory gastrointestinal diseases |
| abstract | The present invention includes a pharmaceutical composition for the prevention or treatment of inflammatory gastrointestinal diseases, in particular ulcerative colitis, Crohn's disease, irritable bowel syndrome, or a gastroenteritis, comprising a Pogostemon Cablin extract as an active ingredient to provide. The broad-spectrum extract effectively inhibits inflammatory bowel disease induced by trinitrobenzene sulfonic acid (TNBS), and also lowers Myeloperoxidase (MPO) activity, thereby preventing ulcerative colitis or Crohn's disease commonly referred to as inflammatory bowel disease. It has prophylactic and therapeutic activity. In addition, the extract of Gwangyang fragrance not only has a prophylactic and therapeutic activity against irritable bowel syndrome by inhibiting contraction of the small intestine and large intestine circumferential muscle, but also has a cytoprotective activity against damaged gastric mucosa, thereby preventing and preventing gastritis. It has therapeutic activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016190546-A1 |
| priorityDate | 2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.